CTRI/2024/01/061744尚未招募Unknown
Real life evidence of Tab Ribociclib for Safety and Efficacy in a tertiary care centre (RERISE study). - NI
ot applicable0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1 Patients with histopathologically confirmed ER or PR positive and HER2 negative locally advanced or metastatic breast cancer
- •2 Patients who have been started on Ribocliclib with atleast one record of treatment with Ribociclib from the year Jun 2018 till December 2022 will be included in study. Data will be collected from the EMR
排除标准
- •1.Patient with HER2 positive metastatic cancer.
- •2.Patients with no available data on EMR.
研究者
相似试验
已完成
不适用
A study to evaluate the effectiveness safety and tolerability of Ribociclib in Indian women with advanced Breast Cancer.CTRI/2022/04/042230ovartis Healthcare Private Limited410
招募中
不适用
Effect of Rivaroxaban in Coronary artery disease patients - Observational studyCTRI/2021/05/033907Emcure Pharmaceuticals Limited
已完成
不适用
The Real-World Data of Treatment with Abemaciclib for HR-positive HER2-negative Metastatic Breast Cancer: A Multicentral Cohort StudyHR-positive HER2-negative Metastatic Breast CancerJPRN-UMIN000043149Aichi Cancer Center200
招募中
不适用
Real-World Evidence Study on AbeMaciclib Treatment Patterns and Effectiveness in Patients with HR+/HER2- Locally Advanced or Metastatic BReAst CancEr in Kuwait and Lebanon.locally advanced or metastatic breast cancerT51.2Breast CancerLBCTR2022035014Eli Lilly100
进行中（未招募）
1 期
Clinical research study to find out if the combination of two study drugs called ribociclib and trametinib is safe and has beneficial effects in people who have solid tumorsSolid tumors, Pancreatic Cancer, Colorectal CancerMedDRA version: 20.0 Level: LLT Classification code 10049280 Term: Solid tumour System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10061451 Term: Colorectal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10033604 Term: Pancreatic cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-005019-34-BEovartis Pharma Services AG153